Palliation of soft tissue cancer pain with radiofrequency ablation

Journal of Supportive Oncology

Volumn 2, Issue 5, 2004, Pages 439-445

  Locklin, Julia K ^a   Mannes, Andrew ^a   Berger, Ann ^a   Wood, Bradford J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; KETOROLAC;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEASIBILITY STUDY; HISTOLOGY; HUMAN; OUTCOMES RESEARCH; PAIN ASSESSMENT; POSTOPERATIVE PAIN; RISK ASSESSMENT; SCORING SYSTEM; SOFT TISSUE CANCER; SOFT TISSUE TUMOR; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; TUMOR VOLUME;

CATHETER ABLATION; HUMANS; PAIN MEASUREMENT; PAIN, INTRACTABLE; PALLIATIVE CARE; RETROSPECTIVE STUDIES; SOFT TISSUE NEOPLASMS;

EID: 7044270939     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Levy MH, Rosen SM, Ottery FD, Hermann J. Supportive care in oncology. Curr Probl Cancer 1992;16:329-418.
2. Onofrio BM. Radiofrequency percutaneous gasserian ganglion lesions: results in 140 patients with trigeminal pain. J Neurosurg 1975;42:132-139.
3. Slappendel R, Crul BJ, Braak GJ, et al. The efficacy of radiofrequency lesioning of the cervical spinal dorsal root ganglion in a double blinded randomized study: no difference between 40 degrees C and 67 degrees C treatments. Pain 1997;73:159-163.
4. Sanders M, Zuurmond WW. Efficacy of sphenopalatine ganglion blockade in 66 patients suffering from cluster headache: a 12- to 70-month follow-up evaluation. J Neurosurg 1997;87:876-880.
5. Sollitto RJ, Plotkin E, Klein PG, Mullin P. Early clinical results of the use of radiofrequency lesioning in the treatment of plantar fasciitis. J Foot Ankle Surg 1997;36:215-219.
6. Oturai AB, Jensen K, Eriksen J, Madsen F. Neurosurgery for trigeminal neuralgia: comparison of alcohol block, neurectomy, and radiofrequency coagulation. Clin J Pain 1996;12:311-315.
7. Stolker RJ, Vervest AC, Groen GJ. The treatment of chronic thoracic segmental pain by radiofrequency percutaneous partial rhizotomy. J Neurosurg 1994;80:986-992.
8. Tillotson CL, Rosenberg AE, Rosenthal DI. Controlled thermal injury of bone: report of a percutaneous technique using radiofrequency electrode and generator. Invest Radiol 1989;24:888-892.
9. Janjan NA, Payne R, Gillis T, et al. Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases. J Pain Symptom Manage 1998;16:171-178.
10. Rosenthal DI, Hornicek FJ, Wolfe MW, et al. Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am 1998;80:815-821.
11. Dupuy DE, Safran H, Mayo-Smith WW, Goldberg SN. Radiofrequency ablation of painful osseous metastatic disease. In: Program/Proceedings of the 84th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA); November 29-December 3, 1998; Chicago, III. Abstract 389.
12. Pacak K, Fojo T, Goldstein DS, et al. Radiofrequency ablation: a novel approach for the treatment of metastatic pheochromocytoma. J Natl Cancer Inst 2001;93:648-649.
13. Wood BJ, Fojo A, Levy EB, et al. Radiofrequency ablation of painful neoplasms as a palliative therapy: early experience. J Vasc Interv Radiol 2000;11S:207.
14. Callstrom MR, Charboneau JW, Goetz MP, et al. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology 2002;224:87-97.
15. Goetz MP, Callstrom MR, Charboneau JW, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 2004;22:300-306.
16. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities. Part II. J Vasc Interv Radiol 2001;12:1135-1148.
17. McDowell I, Newell C. Pain measurements. In: Measuring Health: A Guide to Rating Scales and Questionnaires. 2nd Ed. New York, NY: Oxford University Press; 1996:352-356.
18. Cleeland CS. Pain assessment in cancer. In: Osoba D, ed. Effect of Cancer on Quality of Life. Boca Raton, Fla: CRC Press. 1991;293-305.
19. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003;226:441-451.
20. Livraghi T, Gazelle GS, Goldberg SN, et al. Radiofrequency (RF) ablation of large hepatocellular carcinomas (HCC). In: Program/Proceedings of the 84th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA); November 29-December 3, 1998; Chicago, III. Abstract 266.
21. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 1998;170:1015-1022.
22. Solbiati L, Goldberg SN, Ierace T, et al. Long-term follow-up of liver metastases treated with percutaneous US-guided radiofrequency (RF) ablation using internally-cooled electrodes. In: Program/Proceedings of the 84th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA); November 29-December 3, 1998; Chicago, III. Abstract 449.
23. Goldberg SN, Gazelle GS, Dawson SL, et al. Tissue ablation with radiofrequency using multiprobe arrays. Acad Radiol 1995;2:670-674.
24. Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol 1996;3:636-644.
25. Solbiati L. New applications of ultrasonography: interventional ultrasound. Eur J Radiol 1998;27(suppl 2):S200-S206.
26. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1-8.
27. Letcher FS, Goldring S. The effect of radiofrequency current and heat on peripheral nerve action potential in the cat. J Neurosurg 1968;29:42-47.
28. Janjan NA. Radiation for bone metastases: conventional techniques and the role of systemic radiopharmaceuticals. Cancer 1997;80(8 suppl):1628-1645.